Nilotinib therapy does not induce consistent modifications of cholesterol metabolism resulting in clinical consequences

被引：4
作者：
Breccia, Massimo [1 ]
Loglisci, Giuseppina [1 ]
Cannella, Laura [1 ]
Serrao, Alessandra [1 ]
Colafigli, Gioia [1 ]
Salaroli, Adriano [1 ]
Alimena, Giuliana [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Human Cellular Biotechnol & Hematol, I-00161 Rome, Italy
来源：
LEUKEMIA RESEARCH | 2011年 / 35卷 / 11期
关键词：
CHRONIC MYELOID-LEUKEMIA; IMATINIB;
D O I：
10.1016/j.leukres.2011.07.026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E215 / E216
页数：2
相关论文
共 10 条
[1]   Discoidin Domain Receptor-1 Deficiency Attenuates Atherosclerotic Calcification and Smooth Muscle Cell-Mediated Mineralization [J].
Ahmad, Pamela J. ;
Trcka, Daniel ;
Xue, Siming ;
Franco, Christopher ;
Speer, Mei Y. ;
Giachelli, Cecilia M. ;
Bendeck, Michelle P. .
AMERICAN JOURNAL OF PATHOLOGY, 2009, 175 (06) :2686-2696
[2]  
AICHBERGER KJ, 2011, AM J HEMATOL
[3]  
[Anonymous], BLOOD
[4]  
Breccia M., 2007, LEUKEMIA RES, V31, P1765
[5]   Nilotinib: A second-generation tyrosine kinase inhibitor for chronic myeloid leukemia [J].
Breccia, Massimo ;
Alimena, Giuliana .
LEUKEMIA RESEARCH, 2010, 34 (02) :129-134
[6]   Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase [J].
Cortes, Jorge E. ;
Jones, Dan ;
O'Brien, Susan ;
Jabbour, Elias ;
Konopleva, Marina ;
Ferrajoli, Alessandra ;
Kadia, Tapan ;
Borthakur, Gautam ;
Stigliano, Denise ;
Shan, Jianqin ;
Kantarjian, Hagop .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) :392-397
[7]   Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib [J].
Day, Elizabeth ;
Waters, Beatrice ;
Spiegel, Katrin ;
Alnadaf, Tanja ;
Manley, Paul W. ;
Buchdunger, Elisabeth ;
Walker, Christoph ;
Jarai, Gabor .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 599 (1-3) :44-53
[8]   Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results [J].
Kantarjian, Hagop M. ;
Giles, Francis J. ;
Bhalla, Kapil N. ;
Pinilla-Ibarz, Javier ;
Larson, Richard A. ;
Gattermann, Norbert ;
Ottmann, Oliver G. ;
Hochhaus, Andreas ;
Radich, Jerald P. ;
Saglio, Giuseppe ;
Hughes, Timothy P. ;
Martinelli, Giovanni ;
Kim, Dong-Wook ;
Shou, Yaping ;
Gallagher, Neil J. ;
Blakesley, Rick ;
Baccarani, Michele ;
Cortes, Jorge ;
le Coutre, Philipp D. .
BLOOD, 2011, 117 (04) :1141-1145
[9]   Analysis of glucose profiles in imatinib-resistant or intolerant chronic myelogenous leukemia (CML) patients (pts)treated with nilotinib: Lack of correlation between glucose levels and nilotinib efficacy. [J].
le Coutre, Philipp ;
Giles, Francis J. ;
Hochhaus, Andreas ;
Martinelli, Giovanni ;
Wang, Jim ;
Passos, Vanessa ;
Kayath, Marcia ;
Baccarani, Michele ;
Kantarjian, Hagop M. .
BLOOD, 2007, 110 (11) :219B-219B
[10]   Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia [J].
Saglio, Giuseppe ;
Kim, Dong-Wook ;
Issaragrisil, Surapol ;
le Coutre, Philipp ;
Etienne, Gabriel ;
Lobo, Clarisse ;
Pasquini, Ricardo ;
Clark, Richard E. ;
Hochhaus, Andreas ;
Hughes, Timothy P. ;
Gallagher, Neil ;
Hoenekopp, Albert ;
Dong, Mei ;
Haque, Ariful ;
Larson, Richard A. ;
Kantarjian, Hagop M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (24) :2251-2259
1